| 1 |
Saul, J. M., Annapragada, A., Natarajan, J. V., and Bellamkonda, R. V. "Controlled targeting of liposomal doxorubicin via the folate receptor in vitro" J. Control. Release 92, 49-67 (2003).
DOI
ScienceOn
|
| 2 |
Lee, S. -M., Lee, O. -S., O'Halloran, T. V., Schatz, G. C., and Nguyen, S. T. "Triggered Release of Pharmacophores from [Ni( )]-Loaded Polymer-Caged Nanobin Enhances Proapoptotic Activity: A Combined Experimental and Theoretical Study" ACS Nano 5, 3961-3969 (2011).
DOI
ScienceOn
|
| 3 |
Nayak, S., and Lyon, L. A. "Soft Nanotechnology with Soft Nanoparticles" Angew. Chem., Int. Ed. 44, 7686-7708 (2005).
DOI
ScienceOn
|
| 4 |
Binder, W. H. "Polymer-Induced Transient Pores in Lipid Membranes" Angew. Chem., Int. Ed. 47, 3092-3095 (2008).
DOI
ScienceOn
|
| 5 |
Tannock, I. F., and Rotin, D. "Acid pH in Tumors and Its Potential for Therapeutic Exploitation" Cancer Res. 49, 4373-4384 (1989).
|
| 6 |
Salnikow, K., Donald, S. P., Bruick, R. K., Zhitkovich, A., Phang, J. M., and Kasprzak, K. S. "Depletion of Intracellular Ascorbate by the Carcinogenic Metals Nickel and Cobalt Results in the Induction of Hypoxic Stress" J. Biol. Chem. 279, 40337-40344 (2004).
DOI
ScienceOn
|
| 7 |
Low, P. S., Henne, W. A., and Doorneweerd, D. D. "Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases" Acc. Chem. Res. 41, 120-129 (2008).
DOI
ScienceOn
|
| 8 |
Lee, R. J., and Low, P. S. "Delivery of liposomes into cultured KB cells via folate receptor- mediated endocytosis" J. Biol. Chem. 269, 3198-3204 (1994).
|
| 9 |
Zhu, J., Chen, Z., Lallemand-Breitenbach, V., and de The, H. "How acute promyelocytic leukaemia revived arsenic" Nat. Rev. Cancer 2, 705-714 (2002).
DOI
ScienceOn
|
| 10 |
Uslu, R., Sanli, U. A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S. B., and Goker, E. "Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines" Clin. Cancer Res. 6, 4957-4964 (2000).
|
| 11 |
Dilda, P. J., and Hogg, P. J. "Arsenical-based cancer drugs" Cancer Treat. Rev. 33, 542-564 (2007).
DOI
ScienceOn
|
| 12 |
Lee, S. -M., Chen, H., Dettmer, C. M., O'Halloran, T. V., and Nguyen, S. T. "Polymer-Caged Liposomes: A pH-Responsive Delivery System with High Stability" J. Am. Chem. Soc. 129, 15096-15097 (2007).
DOI
ScienceOn
|
| 13 |
You, E. -A., Ahn, R. W., Lee, M. H., Raja, M. R., O'Halloran, T. V., and Odom, T. W. "Size Control of Arsenic Trioxide Nanocrystals Grown in Nanowells" J. Am. Chem. Soc. 131, 10863-10865 (2009).
DOI
ScienceOn
|
| 14 |
Ahn, R. W., Chen, F., Chen, H., Stern, S. T., Clogston, J. D., Patri, A. K., Raja, M. R., Swindell, E. P., Parimi, V., Cryns, V. L., and O'Halloran, T. V. "A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer" Clin. Cancer Res. 16, 3607-3617 (2010).
DOI
|
| 15 |
Chen, H., MacDonald, R. C., Li, S., Krett, N. L., Rosen, S. T., and O'Halloran, T. V. "Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug Release" J. Am. Chem. Soc. 128, 13348-13349 (2006).
DOI
ScienceOn
|
| 16 |
Lee, S. -M., Chen, H., O'Halloran, T. V., and Nguyen, S. T. "'Clickable' Polymer-Caged Nanobins as a Modular Drug Delivery Platform" J. Am. Chem. Soc. 131, 9311-9320 (2009).
DOI
ScienceOn
|
| 17 |
Donaldson, M., Antignani, A., Milner, J., Zhu, N., Wood, A., Cardwell-Miller, L., Changpriroa, C. M., and Jackson, S. H. "p47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosis" Cell Death Differ. 16, 125-138 (2009).
DOI
ScienceOn
|
| 18 |
Rostovtsev, V. V., Green, L. G., Fokin, V. V., and Sharpless, K. B. "A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective "Ligation" of Azides and Terminal Alkynes" Angew. Chem., Int. Ed. 41, 2596-2599 (2002).
DOI
ScienceOn
|
| 19 |
Davis, M. E., Chen, Z., and Shin, D. M. "Nanoparticle therapeutics: an emerging treatment modality for cancer" Nat. Rev. Drug Discovery 7, 771-782 (2008).
DOI
ScienceOn
|
| 20 |
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. "Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review" J. Controlled Release 65, 271-284 (2000).
DOI
ScienceOn
|
| 21 |
Li, S. -D., and Huang, L. "Pharmacokinetics and Biodistribution of Nanoparticles" Mol. Pharmaceutics 5, 496-504 (2008).
DOI
ScienceOn
|
| 22 |
Gabizon, A. A. "Stealth Liposomes and Tumor Targeting: One Step Further in the Quest for the Magic Bullet" Clin. Cancer Res. 7, 223-225 (2001).
|
| 23 |
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., and Papahadjopoulos, D. "Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors" Pharmacol. Rev. 51, 691-744 (1999).
|
| 24 |
Barenholz, Y. "}$} "$Doxil^{(R)}$") - The first FDA-approved nano-drug: Lessons learned" J. Controlled Release 160, 117-134 (2012).
DOI
ScienceOn
|
| 25 |
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., and Herbst, R. S. "A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer" Lung Cancer 34, 427-432 (2001).
DOI
ScienceOn
|
| 26 |
Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., and Stewart, J. S. W. "Phase I-II study of pegylated liposomal cisplatin (SPI- ) in patients with inoperable head and neck cancer" Ann. Oncol. 12, 493-496 (2001).
DOI
ScienceOn
|
| 27 |
Bandak, S., Goren, D., Horowitz, A., Tzemach, D., and Gabizon, A. "Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models" Anti-Cancer Drugs 10, 911-920 (1999).
DOI
|
| 28 |
Allen, T. M., and Cullis, P. R. "Drug delivery systems: Entering the mainstream" Science 303, 1818-1822 (2004).
DOI
ScienceOn
|
webmaster
